Terazosin hydrochloride anhydrous
- Level
- Commodity
- Parent
- 51263000
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51263011This classification denotes an alpha-adrenergic blocking agent with the molecular formula C19H25N5O4.CLH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8QOP8Z9955. European Medicines Agency schedules terazosin hcl in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04722MIG. Most nations, for tariff and trade purposes, schedule terazosin hydrochloride anhydrous under HS 29349990 and SITC 51579. As of Q4 2014, TERAZOSIN HYDROCHLORIDE ANHYDROUS remains US FDA's Preferred Term for this commodity. Terazosin hydrochloride anhydrous bears US NLM identifiers UMLS ID C2241271 and NCI Concept Code C75056. SMILES: COC1CC2C(CC1OC)NC(NC2N)N3CCN(CC3)C(=O)C4CCCO4.CL.
Same parent
Under 51263000 · 17Activities that produce or sell this
KBLI · 8Inherited from family 51260000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.